Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to The University of Kansas Cancer Center - Olathe · Olathe, Kansas
Answer a few short questions to share with the research team.